InvestorsHub Logo

Sprycel

02/05/09 9:14 AM

#6201 RE: The Holder #6197

Actually as what my oncologist friend told me is TESETAXEL in fact WILL be larger than Genesense for revenue purposes because TESETAXEL is used in MULTIPLE types of cancers where GENESENSE will be targeted initially for CLL treatment. If you show the information on TESETAXEL to an oncologist and ask them what they think TESETAXEL's potential is you will be very surprised!! Just some DD and why my oncologist friend and his business associate each bought 1 million shares!! They told me if TESETAXEL is effective in dosing TAXANES orally instead of through costly infused intravenous it will be the first line treatment. You can take a pill at home or come into a cancer clinic and sit through an administered intravenous line! He said it is a no brainer for first consideration treatment!!